Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06224218 · ClinicalTrials.gov registry record · NA
Prostate Single Port & Laser Enucleation Comparison Trial
A NA study of Prostate Hyperplasia, sponsored by University of Illinois at Chicago.
- Recruiting
- Registry status
- NA
- Development phase
- 116
- Enrollment target
- 1
- Study location
NCT06224218 is a NA study of Prostate Hyperplasia that is actively recruiting participants, run by University of Illinois at Chicago. The registered enrollment target is 116 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06224218, a NA study of Prostate Hyperplasia, is actively recruiting participants, sponsored by University of Illinois at Chicago.
- RECRUITING
- Registry status
- NA
- Development phase
- 116 participants
- Enrollment target
- 1
- Study location
Study Summary
Surgical treatments for benign prostatic hyperplasia (BPH) are necessary when non-procedural approaches fail to alleviate lower urinary tract symptoms (LUTS) or bladder outlet obstruction (BOO). Open simple prostatectomy and laser enucleation are recommended for prostatic adenoma size greater than 80 ml. Minimally invasive approaches, such as robotic-assisted simple prostatectomy, have gained popularity due to their comparable outcomes with lower morbidity. The introduction of the da Vinci single-port (SP) robotic platform offers potential advantages, but its outcomes have not been thoroughly investigated. This randomized controlled trial aims to compare the outcomes of SP simple prostatectomy performed using the da Vinci robotic platform versus thulium laser enucleation of the prostate for the treatment of BPH and BOO.
Conditions Studied
Interventions
- PROCEDURE Single Port Robotic Surgery
- PROCEDURE Laser Surgery
Study Locations (1)
Illinois
- UI Health SCB Clinic Department of Urology - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 116 participants |
| Start Date | 2024-01-15 |
| Est. Completion | 2027-08-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06224218
The ClinicalTrials.gov registry entry for NCT06224218 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 116 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Prostate Hyperplasia appearing as the primary indexed condition, and to 2 interventions - of which Single Port Robotic Surgery is the first listed.
NCT06224218 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT06224218 about?
NCT06224218 is a clinical study titled "Prostate Single Port & Laser Enucleation Comparison Trial". Surgical treatments for benign prostatic hyperplasia (BPH) are necessary when non-procedural approaches fail to alleviate lower urinary tract symptoms (LUTS) or bladder outlet obstruction (BOO). Open simple prostatectomy and laser enucleation are recommended for prostatic adenoma size greater than 8...
What is the current status of trial NCT06224218?
This trial is currently recruiting. It is a NA study. The enrollment target is 116 participants. The study started on 2024-01-15. Estimated completion is 2027-08-15.
What conditions does trial NCT06224218 study?
This clinical trial studies the following conditions: Prostate Hyperplasia.
What interventions are being tested in trial NCT06224218?
The interventions under investigation include: Single Port Robotic Surgery (PROCEDURE), Laser Surgery (PROCEDURE).
Who is sponsoring clinical trial NCT06224218?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06224218 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Hyperplasia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.